193 related articles for article (PubMed ID: 38150499)
1. B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations.
Wu CG; Balakrishnan VK; Merrill RA; Parihar PS; Konovolov K; Chen YC; Xu Z; Wei H; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Chung WK; Honkanen RE; Suzuki A; Huang X; Strack S; Xing Y
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2310727120. PubMed ID: 38150499
[TBL] [Abstract][Full Text] [Related]
2. Extended regulation interface coupled to the allosteric network and disease mutations in the PP2A-B56δ holoenzyme.
Wu CG; Balakrishnan VK; Parihar PS; Konovolov K; Chen YC; Merrill RA; Wei H; Carragher B; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Honkanen R; Chung WK; Suzuki A; Strack S; Huang X; Xing Y
bioRxiv; 2023 Apr; ():. PubMed ID: 37066309
[TBL] [Abstract][Full Text] [Related]
3. Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition.
Li Y; Balakrishnan VK; Rowse M; Wu CG; Bravos AP; Yadav VK; Ivarsson Y; Strack S; Novikova IV; Xing Y
Elife; 2022 Aug; 11():. PubMed ID: 35924897
[TBL] [Abstract][Full Text] [Related]
4. Quantum-based modeling implies that bidentate Arg
Salter EA; Wierzbicki A; Honkanen RE; Swingle MR
Front Cell Dev Biol; 2023; 11():1141804. PubMed ID: 37377738
[TBL] [Abstract][Full Text] [Related]
5. PPM1G forms a PPP-type phosphatase holoenzyme with B56δ that maintains adherens junction integrity.
Kumar P; Tathe P; Chaudhary N; Maddika S
EMBO Rep; 2019 Oct; 20(10):e46965. PubMed ID: 31432583
[TBL] [Abstract][Full Text] [Related]
6. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades.
Smolen KA; Papke CM; Swingle MR; Musiyenko A; Li C; Salter EA; Camp AD; Honkanen RE; Kettenbach AN
J Biol Chem; 2023 Sep; 299(9):105154. PubMed ID: 37572851
[TBL] [Abstract][Full Text] [Related]
8. β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
Ranieri A; Kemp E; Burgoyne JR; Avkiran M
J Mol Cell Cardiol; 2018 Feb; 115():20-31. PubMed ID: 29294329
[TBL] [Abstract][Full Text] [Related]
9. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
Biswas D; Cary W; Nolta JA
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
[TBL] [Abstract][Full Text] [Related]
10. Disease mutations and phosphorylation alter the allosteric pathways involved in autoinhibition of protein phosphatase 2A.
Konovalov KA; Wu CG; Qiu Y; Balakrishnan VK; Parihar PS; O'Connor MS; Xing Y; Huang X
J Chem Phys; 2023 Jun; 158(21):. PubMed ID: 37260014
[TBL] [Abstract][Full Text] [Related]
11. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.
Dodge-Kafka KL; Bauman A; Mayer N; Henson E; Heredia L; Ahn J; McAvoy T; Nairn AC; Kapiloff MS
J Biol Chem; 2010 Apr; 285(15):11078-86. PubMed ID: 20106966
[TBL] [Abstract][Full Text] [Related]
12. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE
J Biol Chem; 2021; 296():100313. PubMed ID: 33482199
[TBL] [Abstract][Full Text] [Related]
13. Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity.
Low IC; Loh T; Huang Y; Virshup DM; Pervaiz S
Blood; 2014 Oct; 124(14):2223-34. PubMed ID: 25082878
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A.
Yu UY; Ahn JH
BMB Rep; 2010 Apr; 43(4):263-7. PubMed ID: 20423611
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care.
Levine AD; Chung WK
Cold Spring Harb Mol Case Stud; 2023 Jun; 9(3):. PubMed ID: 37339871
[TBL] [Abstract][Full Text] [Related]
16. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.
Kuo YC; Huang KY; Yang CH; Yang YS; Lee WY; Chiang CW
J Biol Chem; 2008 Jan; 283(4):1882-92. PubMed ID: 18042541
[TBL] [Abstract][Full Text] [Related]
17. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
18. PP2A/B55α substrate recruitment as defined by the retinoblastoma-related protein p107.
Fowle H; Zhao Z; Xu Q; Wasserman JS; Wang X; Adeyemi M; Feiser F; Kurimchak AN; Atar D; McEwan BC; Kettenbach AN; Page R; Peti W; Dunbrack RL; Graña X
Elife; 2021 Oct; 10():. PubMed ID: 34661528
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C-dependent dephosphorylation of tyrosine hydroxylase requires the B56δ heterotrimeric form of protein phosphatase 2A.
Ahn JH; Kim Y; Kim HS; Greengard P; Nairn AC
PLoS One; 2011; 6(10):e26292. PubMed ID: 22046270
[TBL] [Abstract][Full Text] [Related]
20. De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
Shang L; Henderson LB; Cho MT; Petrey DS; Fong CT; Haude KM; Shur N; Lundberg J; Hauser N; Carmichael J; Innis J; Schuette J; Wu YW; Asaikar S; Pearson M; Folk L; Retterer K; Monaghan KG; Chung WK
Neurogenetics; 2016 Jan; 17(1):43-9. PubMed ID: 26576547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
